Epicept Corporation (EPCT) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	317K
Inventory
Prepaid expenses and other current assets
Total current assets	498K
Restricted cash
Property and equipment, net	335K
Long-term inventory
Deferred financing costs
Total assets	31.55M
Accounts payable	3.5M
Accrued research contract costs
Other accrued liabilities
Notes and loans payable, current portion	1.69M
Deferred revenue, current portion
Total current liabilities	7.08M
Notes and loans payable
7.5556% Convertible Subordinated Notes Due 2014
Deferred revenue
Deferred rent and other noncurrent liabilities
Total liabilities	19.89M
Commitments and contingencies	0
Common stock, $.0001 par value; authorized 225,000,000 shares; issued 71,007,834 and 54,991,535 shares at June 30, 2011 and December 31, 2010, respectively	11K
Additional paid-in capital	95.68M
Warrants
Accumulated deficit	-84.02M
Accumulated other comprehensive loss
Treasury stock, at cost (4,167 shares)
Total stockholders' deficit	11.67M
Total liabilities and stockholders' deficit	31.55M

Entities mentioned with EPCT

View All Entities